✦ LIBER ✦

101 Cerivastatin—a new HMG-CoA reductase inhibitor—in combination with the antacid Maalox®: an investigation of the safety and pharmacokinetics

✍ Scribed by H. Dietrich; W. Ritter; W. Wingender; S. Unger; K. Ochmann

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

103 Phase I study to investigate the eff

✍ R. Frey; W. Ritter; S. Unger; K. Ochmann; W. Wingender 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Single- and multiple-dose pharmacokineti

✍ M.J Warwick; A.L Dane; A Raza; D.W Schneck 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 137 KB

The Safety Evaluation of Fluvastatin, an

✍ Howard A. Hartman; Laurie A. Myers; Morton Evans; Rodney L. Robison; Robert G. E 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 148 KB

EFFECT OF THE NEW HMG-CoA REDUCTASE INHI

✍ A. CORSINI; L. ARNABOLDI; M. RAITERI; P. QUARATO; A. FAGGIOTTO; R. PAOLETTI; R. 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Effect of cerivastatin sodium, a new inh

✍ Masashi Shiomi; Takashi Ito 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 552 KB

A double-blind controlled trial on the e

✍ Terry A. Jacobson; Margaret Chin; Gregg Fromell; Louis F. Amorosa; Leonard A. Jo 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 159 KB